(Q44264995)

1 December 2017

title

Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation (English)

1 reference

1 December 2017

0 references

0 references

0 references

3

Billy R Martin

1 reference

1 December 2017

Nissar A Darmani

1

1 reference

1 December 2017

Laura J Sim-Selley

2

1 reference

1 December 2017

Jano J Janoyan

4

1 reference

1 December 2017

Jennifer L Crim

5

1 reference

1 December 2017

Bavita Parekh

6

1 reference

1 December 2017

Christopher S Breivogel

7

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

European Journal of Pharmacology

1 December 2017

published in

1 reference

1 December 2017

volume

459

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

83-95

1 reference

Neurobiology of marijuana abuse.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

The functional neuroanatomy of brain cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

The endocannabinoid system: a physiological perspective on its role in psychomotor control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Delta9-tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Δ9-Tetrahydrocannabinol for Refractory Vomiting Induced by Cancer Chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Pharmacological agents affecting emesis. A review (Part I)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Cannabis and cannabinoids: pharmacology and rationale for clinical use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

2-Arachidonoylglycerol and the cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902815-7

10.1016/S0014-2999(02)02815-7

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference